You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR BREXANOLONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for brexanolone

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02603926 ↗	Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone	Completed	Randi J. Hagerman, MD	Phase 2	2015-10-01	The purpose of this study is to examine the safety and efficacy of Allopregnanolone as a possible treatment for symptoms of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS).
NCT02603926 ↗	Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone	Completed	University of California, Davis	Phase 2	2015-10-01	The purpose of this study is to examine the safety and efficacy of Allopregnanolone as a possible treatment for symptoms of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS).
NCT03665038 ↗	A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)	Completed	Sage Therapeutics	Phase 3	2018-05-17	This is a multi-center study evaluating the safety, tolerability, and pharmacokinetics of brexanolone in the treatment of adolescent female participants with postpartum depression.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for brexanolone

Condition Name

Chart
Table

Condition Name for brexanolone
Intervention	Trials
Postpartum Depression	3
Postpartum Psychosis	1
PTSD	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for brexanolone
Intervention	Trials
Depression, Postpartum	4
Depressive Disorder	3
Depression	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for brexanolone

Trials by Country

Map
Table

Trials by Country for brexanolone
Location	Trials
United States	23
Australia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for brexanolone
Location	Trials
North Carolina	3
California	3
Georgia	2
Connecticut	1
Washington	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for brexanolone

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for brexanolone
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	2
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for brexanolone
Clinical Trial Phase	Trials
Not yet recruiting	6
Completed	2
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for brexanolone

Sponsor Name

Chart
Table

Sponsor Name for brexanolone
Sponsor	Trials
Sage Therapeutics	8
Donald Jeffrey Newport	1
University of North Carolina, Chapel Hill	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for brexanolone
Sponsor	Trials
Industry	9
Other	6
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.